Date:	--/--/-- --:--:--
Event Id:	E5CZIC4PD
Action Type:	ACQUISITION
Action Status:	REJECTED
Acquirer Symbol:
Target Symbol:	SAGE
Updated:	--/--/-- --:--:--
Purchase Price Per Share:	7.22
Price Per Share Currency:	USD
News References:	https://www.businesswire.com/news/home/20250126284706/en/

Action Notes

Biogen Inc. (Biogen) has submitted a nonbinding proposal to acquire all of the outstanding shares of Sage Therapeutics, Inc. (Sage) not already owned by Biogen for $7.22 per share. The Sage Board of Directors will carefully review and evaluate the proposal.